Cargando…

Role of Proteases in Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is generally associated with progressive destruction of airways and lung parenchyma. Various factors play an important role in the development and progression of COPD, like imbalance of proteases, environmental and genetic factors and oxidative stress. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Kailash C., De, Sajal, Mishra, Pradyumna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5550664/ https://www.ncbi.nlm.nih.gov/pubmed/28848433 http://dx.doi.org/10.3389/fphar.2017.00512

Ejemplares similares

Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets
por: Verma, Sonia, et al.
Publicado: (2016)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Proteases and Their Inhibitors in Chronic Obstructive Pulmonary Disease
por: Dey, Tapan, et al.
Publicado: (2018)

Drug Safety of Benzodiazepines in Asian Patients With Chronic Obstructive Pulmonary Disease
por: Liao, Yi-Hsiang, et al.
Publicado: (2020)

Effect of pulmonary rehabilitation on heart rate recovery in adult individuals with asthma or chronic obstructive pulmonary disease
por: Zampogna, Elisabetta, et al.
Publicado: (2022)

Imbalance of Endogenous Hydrogen Sulfide and Homocysteine in Chronic Obstructive Pulmonary Disease Combined with Cardiovascular Disease
por: He, Yanjing, et al.
Publicado: (2017)

Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
por: Tang, Manyun, et al.
Publicado: (2021)

Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
por: Seshadri, Dhruv R., et al.
Publicado: (2018)

The Efficacy and Safety of Revefenacin for the Treatment of Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Zhang, Jiaxing, et al.
Publicado: (2021)

Potential Natural Small Molecular Compounds for the Treatment of Chronic Obstructive Pulmonary Disease: An Overview
por: Li, Liu-Ying, et al.
Publicado: (2022)

Progression of the PI3K/Akt signaling pathway in chronic obstructive pulmonary disease
por: Liu, Yanhui, et al.
Publicado: (2023)

Subjective assessment of quality of sleep in chronic obstructive pulmonary disease patient and its relationship with associated depression
por: De, Sajal
Publicado: (2012)

Roles of autophagy-related genes in the therapeutic effects of Xuanfei Pingchuan capsules on chronic obstructive pulmonary disease based on transcriptome sequencing analysis
por: Zhang, Ye, et al.
Publicado: (2023)

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Pharmacological effects of Bufei Jianpi granule on chronic obstructive pulmonary disease and its metabolism in rats
por: Yang, Xin-Xin, et al.
Publicado: (2022)

Improvement of Airflow Limitation by Fluticasone Propionate/Salmeterol in Chronic Obstructive Pulmonary Disease: What is the Specific Marker?
por: Akamatsu, Keiichiro, et al.
Publicado: (2011)

Herbal Medicine Compared to Placebo for Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
por: Kwon, Chan-Young, et al.
Publicado: (2021)

A Novel Processing-Free Method for RNAseq Analysis of Spontaneous Sputum in Chronic Obstructive Pulmonary Disease
por: Ricci, Francesca, et al.
Publicado: (2021)

Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
por: Facchinetti, Fabrizio, et al.
Publicado: (2021)

Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?
por: Liu, Meiling, et al.
Publicado: (2021)

Self-Reported Overall Adherence and Correct Inhalation Technique Discordance in Chronic Obstructive Pulmonary Disease Population
por: Hendrychova, Tereza, et al.
Publicado: (2022)

The clinical characteristics and treatment response of patients with chronic obstructive pulmonary disease with low body mass index
por: Song, Qing, et al.
Publicado: (2023)

Healthcare Professionals’ Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease
por: Dankers, Marloes, et al.
Publicado: (2020)

Unravelling the Therapeutic Potential of Botanicals Against Chronic Obstructive Pulmonary Disease (COPD): Molecular Insights and Future Perspectives
por: Mitra, Sicon, et al.
Publicado: (2022)

Analyze and Identify Peiminine Target EGFR Improve Lung Function and Alleviate Pulmonary Fibrosis to Prevent Exacerbation of Chronic Obstructive Pulmonary Disease by Phosphoproteomics Analysis
por: Ma, Xiaoyao, et al.
Publicado: (2019)

Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials
por: Chen, Hong, et al.
Publicado: (2021)

Integration of metabolomics and network pharmacology to reveal the protective mechanism underlying Qibai Pingfei capsule on chronic obstructive pulmonary disease
por: Xie, Jinghui, et al.
Publicado: (2023)

miR-4456/CCL3/CCR5 Pathway in the Pathogenesis of Tight Junction Impairment in Chronic Obstructive Pulmonary Disease
por: Yu, Weiwei, et al.
Publicado: (2021)

A real-world cost-effectiveness analysis of nebulized budesonide and intravenous methylprednisolone in acute exacerbation of chronic obstructive pulmonary disease
por: Gu, Yong-Li, et al.
Publicado: (2022)

Efficacy and safety of three species of Rhodiola L. in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
por: Yu, Haichuan, et al.
Publicado: (2023)

Herb-symptom analysis of Erchen decoction combined with Xiebai powder formula and its mechanism in the treatment of chronic obstructive pulmonary disease
por: Ye, Hua, et al.
Publicado: (2023)

Elevated serum matrix metalloprotease (MMP-2) as a candidate biomarker for stable COPD
por: Mahor, Durga, et al.
Publicado: (2020)

Breathing Out Completely Before Inhalation: The Most Problematic Step in Application Technique in Patients With Non-Mild Chronic Obstructive Pulmonary Disease
por: Vytrisalova, Magda, et al.
Publicado: (2019)

Real-world antibiotic use in treating acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in China: Evidence from the ACURE study
por: Ma, Yiming, et al.
Publicado: (2021)

Statin use and Vital Organ Failure in Patients With Asthma–Chronic Obstructive Pulmonary Disease Overlap: A Time-Dependent Population-Based Study
por: Yeh, Jun-Jun, et al.
Publicado: (2019)

Celastrol Alleviates Chronic Obstructive Pulmonary Disease by Inhibiting Cellular Inflammation Induced by Cigarette Smoke via the Ednrb/Kng1 Signaling Pathway
por: Shi, Ke, et al.
Publicado: (2018)

Role of Proteases in Lung Disease: A Brief Overview
por: Chakraborti, Sajal, et al.
Publicado: (2017)

Effect of Bronchodilator and Steroid Use on Heart Disease and Stroke Risks in a Bronchiectasis–Chronic Obstructive Pulmonary Disease Overlap Cohort: A Propensity Score Matching Study
por: Yeh, Jun-Jun, et al.
Publicado: (2019)

Bufei Yishen Formula Restores Th17/Treg Balance and Attenuates Chronic Obstructive Pulmonary Disease via Activation of the Adenosine 2a Receptor
por: Zhao, Peng, et al.
Publicado: (2020)

Monoclonal Antibodies Targeting IL-5 or IL-5Rα in Eosinophilic Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis
por: Zhang, Chuchu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0o920mt72f10i4842593pqjj50